PTPN1 and cervical cancer: Furthermore, SC targeted protein tyrosine phosphatase non-receptor type 1 (PTPN1) and inhibited the activation of the PI3K/AKT signaling pathway, presenting a potential treatment strategy for cervical cancer [78].